Contact
Please use this form to send email to PR contact of this press release:
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
TO:
Please use this form to send email to PR contact of this press release:
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
TO: